JPY 1975.0
(-0.5%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 60.17 Billion | 62.77 Billion | 51.05 Billion | 53.92 Billion | 57.11 Billion | 63.4 Billion |
Cost of Revenue | 54.27 Billion | 56.98 Billion | 46.28 Billion | 45.03 Billion | 49.62 Billion | 54.71 Billion |
Gross Profit | 5.9 Billion | 5.79 Billion | 4.77 Billion | 8.88 Billion | 7.48 Billion | 8.68 Billion |
Operating Expenses | 5.68 Billion | 5.72 Billion | 4.59 Billion | 4.32 Billion | 4.88 Billion | 5.32 Billion |
Selling, General and Administrative Expenses | 5.11 Billion | 5.15 Billion | 4.59 Billion | 4.37 Billion | 5.22 Billion | 5.32 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 575 Million | 340 Million | 294 Million | 169 Million | 325 Million | 139 Million |
Cost and Expenses | 59.38 Billion | 62.71 Billion | 50.87 Billion | 49.36 Billion | 54.5 Billion | 60.03 Billion |
Operating Income | 792 Million | 67 Million | 181 Million | 4.56 Billion | 2.6 Billion | 3.36 Billion |
Interest Expense | 155 Million | 119 Million | 67 Million | 72 Million | 127 Million | 166 Million |
Income Tax Expense | 2.08 Billion | 1.31 Billion | 756 Million | 1.49 Billion | 922 Million | 1.52 Billion |
Earnings before Tax | 4.31 Billion | 2.9 Billion | 1.13 Billion | 4.06 Billion | 2.19 Billion | 5.21 Billion |
Net Income | 2.45 Billion | 1.67 Billion | 559 Million | 2.76 Billion | 1.17 Billion | 3.38 Billion |
Earnings Per Share Basic | 246.02 | 170.29 | 57.07 | 277.87 | 117.25 | 339.63 |
Earnings Per Share Diluted | 211.31 | 157.14 | 56.84 | 275.90 | 116.20 | 334.97 |
Weighted Average Shares Outstanding | 9.98 Million | 9.84 Million | 9.79 Million | 9.94 Million | 10.02 Million | 9.97 Million |
Weighted Average Shares Outstanding (Diluted) | 11.62 Million | 10.66 Million | 9.83 Million | 10.01 Million | 10.11 Million | 10.11 Million |
Gross Margin | 0.10 | 0.09 | 0.09 | 0.16 | 0.13 | 0.14 |
EBIT Margin | 0.05 | 0.08 | 0.05 | 0.10 | 0.08 | 0.07 |
Profit Margin | 0.04 | 0.03 | 0.01 | 0.05 | 0.02 | 0.05 |
EBITDA | 2.92 Billion | 1.91 Billion | 1.47 Billion | 5.79 Billion | 3.65 Billion | 4.46 Billion |
Earnings Before Tax Margin | 0.01 | 0.00 | 0.00 | 0.08 | 0.05 | 0.05 |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 15.17 Billion | 60.17 Billion | 15.35 Billion | 15.42 Billion | 15.85 Billion | 13.54 Billion |
Cost of Revenue | 13.88 Billion | 54.27 Billion | 13.86 Billion | 14.1 Billion | 13.87 Billion | 11.84 Billion |
Gross Profit | 1.28 Billion | 5.9 Billion | 1.49 Billion | 1.31 Billion | 1.97 Billion | 1.69 Billion |
Operating Expenses | 1.47 Billion | 5.11 Billion | 1.59 Billion | 1.29 Billion | 1.43 Billion | 1.36 Billion |
Selling, General and Administrative Expenses | 1.47 Billion | - | 1.59 Billion | 1.29 Billion | 1.43 Billion | 1.36 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 280 Million | -23 Million | 94 Million | 157 Million | 52 Million |
Cost and Expenses | 15.36 Billion | 59.38 Billion | 15.46 Billion | 15.4 Billion | 15.3 Billion | 13.2 Billion |
Operating Income | -190 Million | 794 Million | -102 Million | 18 Million | 542 Million | 335 Million |
Interest Expense | 70 Million | 155 Million | 19 Million | 47 Million | 40 Million | 49 Million |
Income Tax Expense | 612 Million | 2.08 Billion | 545 Million | 239 Million | 685 Million | 617 Million |
Earnings before Tax | 1.42 Billion | 4.31 Billion | 777 Million | 871 Million | 1.33 Billion | 1.33 Billion |
Net Income | 780 Million | 2.45 Billion | 541 Million | 632 Million | 677 Million | 607 Million |
Earnings Per Share Basic | 78.06 | - | 54.14 | 63.28 | 67.79 | 60.78 |
Earnings Per Share Diluted | 67.10 | - | 46.50 | 54.32 | 58.24 | 52.25 |
Weighted Average Shares Outstanding | 11.62 Million | 9.98 Million | 9.99 Million | 9.98 Million | 9.98 Million | 9.98 Million |
Weighted Average Shares Outstanding (Diluted) | 11.62 Million | 11.62 Million | 11.63 Million | 11.63 Million | 11.62 Million | 11.61 Million |
Gross Margin | 0.08 | 0.10 | 0.10 | 0.09 | 0.12 | 0.13 |
EBIT Margin | 0.02 | - | 0.05 | 0.05 | 0.09 | 0.09 |
Profit Margin | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
EBITDA | 342.25 Million | - | 774 Million | 708 Million | 1.35 Billion | 1.27 Billion |
Earnings Before Tax Margin | -0.01 | 0.01 | -0.01 | 0.00 | 0.03 | 0.02 |
PGM
AAREYDRUGS
SUGALDAM
6724
JUBLPHARMA
EKH